These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2172264)

  • 41. Collaborative study on a Guinea pig serological method for the assay of acellular pertussis vaccines.
    Winsnes R; Sesardic D; Daas A; Terao E; Behr-Gross ME
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):27-40. PubMed ID: 20144450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents.
    Hodder SL; Cherry JD; Mortimer EA; Ford AB; Gornbein J; Papp K
    Clin Infect Dis; 2000 Jul; 31(1):7-14. PubMed ID: 10913389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An improved ELISA system for the measurement of IgG antibodies against pertussis toxin (PT) and filamentous hemagglutinin (FHA) in human sera.
    Sato Y; Sato H; Kodama H; Uchimura M; Miwa N; Kobayashi T; Yamamoto E; Fujita I; Kumamoto T
    Dev Biol Stand; 1991; 73():167-74. PubMed ID: 1778310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
    Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of mutant strains producing pertussis toxin cross reacting materials.
    Sato Y; Sato H; Chazono M; Ginnaga A; Tamura C
    Dev Biol Stand; 1991; 73():93-107. PubMed ID: 1778339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel bivalent acellular pertussis vaccine based on the 69 kDa protein and FHA.
    Novotny P; Chubb AP; Cownley K; Charles IG
    Dev Biol Stand; 1991; 73():243-9. PubMed ID: 1778316
    [TBL] [Abstract][Full Text] [Related]  

  • 47. International collaborative study: evaluation of proposed International Reference Reagent of pertussis antiserum (mouse) 97/642.
    Gaines Das R; Xing D; Rigsby P; Newland P; Corbel M
    Biologicals; 2001 Jun; 29(2):137-48. PubMed ID: 11580218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Filamentous hemagglutinin of Bordetella pertussis. A bacterial adhesin formed as a 50-nm monomeric rigid rod based on a 19-residue repeat motif rich in beta strands and turns.
    Makhov AM; Hannah JH; Brennan MJ; Trus BL; Kocsis E; Conway JF; Wingfield PT; Simon MN; Steven AC
    J Mol Biol; 1994 Aug; 241(1):110-24. PubMed ID: 7519681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of toxicities of acellular pertussis vaccine with whole cell pertussis vaccine in experimental animals.
    Sato Y; Sato H
    Dev Biol Stand; 1991; 73():251-62. PubMed ID: 1778317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
    Prince HE; Lapé-Nixon M; Matud J
    Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acellular pertussis vaccine given by accelerated schedule: response of preterm infants.
    Slack MH; Schapira D; Thwaites RJ; Schapira C; Bamber J; Burrage M; Southern J; Andrews N; Miller E
    Arch Dis Child Fetal Neonatal Ed; 2004 Jan; 89(1):F57-60. PubMed ID: 14711858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Bordetella pertussis acellular vaccine candidate: antigenic characterization and antibody induction.
    Dias WO; Horton DS; Takahashi CM; Raw I
    Braz J Med Biol Res; 1994 Nov; 27(11):2607-11. PubMed ID: 7549983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation of IgA, IgM and IgG antibody-detecting assays based on filamentous haemagglutinin, pertussis toxin and Bordetella pertussis sonicate in a strictly adult population.
    Klement E; Kagan N; Hagain L; Kayouf R; Boxman J; Cohen D; Orr N
    Epidemiol Infect; 2005 Feb; 133(1):149-58. PubMed ID: 15724722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
    Sato H; Sato Y
    Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Purification and characterization of Bordetella bronchiseptica dermonecrotic toxin.
    Horiguchi Y; Nakai T; Kume K
    Microb Pathog; 1989 May; 6(5):361-8. PubMed ID: 2770506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of purified pertussis components and lipopolysaccharide on the results of the mouse weight gain test.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    J Biol Stand; 1988 Oct; 16(4):321-31. PubMed ID: 3198661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved pertussis toxin production by Bordetella pertussis through adjusting the growth medium's ionic composition.
    Frohlich BT; De Bernardez Clark ER; Siber GR; Swartz RW
    J Biotechnol; 1995 May; 39(3):205-19. PubMed ID: 7766402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purification of pertussis toxin.
    Perera VY
    Methods Enzymol; 1988; 165():120-6. PubMed ID: 2906727
    [No Abstract]   [Full Text] [Related]  

  • 59. Maintenance of biological activity of pertussis toxin radioiodinated while bound to fetuin-agarose.
    Armstrong GD; Peppler MS
    Infect Immun; 1987 May; 55(5):1294-9. PubMed ID: 2437034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of the filamentous hemagglutinin from Bordetella pertussis by gel electrophoresis.
    An der Lan B; Cowell JL; Burstyn DG; Manclark CR; Chrambach A
    Mol Cell Biochem; 1986 Apr; 70(1):31-55. PubMed ID: 2872590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.